Goodsurance
ES

Policy & oversight

OIG: Medicare Improperly Paid 15.2 Million Dollars for Sacroiliac Joint Injections

A new federal audit found that physician billing for lower-back and pelvis pain injections did not meet Medicare coverage and documentation rules, producing millions in improper payments.

By the Goodsurance editorial teamAugust 11, 2026

The HHS Office of Inspector General published an audit on August 3 finding that Medicare improperly paid physicians an estimated 15.2 million dollars for sacroiliac joint injections. Sacroiliac joint injections are a pain management procedure targeting the joint that connects the spine to the pelvis. Federal auditors reviewed a sample of claims and found that a share of them did not meet Medicare's coverage requirements or documentation standards. The OIG is recommending that CMS direct Medicare Administrative Contractors to recover improper payments and strengthen oversight of this billing category. The report, numbered OAS-25-09-021, continues a line of OIG spinal pain audits that have previously flagged improper payments for facet joint injections and epidural steroid injections. Together, these audits point to broader vulnerabilities in how Medicare pays for injected pain management services. CMS has not publicly responded to this specific report.

OIG says Medicare paid 15.2 million dollars for back-pain injections that did not meet coverage rules.

In plain words

A government watchdog checked Medicare payments for a kind of back-pain shot. It found that Medicare paid doctors 15.2 million dollars for shots that did not follow the rules. The watchdog says Medicare should try to get that money back and watch this type of billing more closely.

Source: HHS Office of Inspector General
Read at the source →

More news

Other stories on what is moving in Medicare.

Policy & oversight

Federal Watchdog: Medicare Billing Oversight Caught Only 8 of 234 Contractor Errors

A new OIG audit found that CMS quality reviews identified just 8 of 234 settlement mistakes by Medicare's billing contractors, with 31.6 million dollars in corrected payments at stake.

November 10, 2026

Policy & oversight

CMS Proposes Removing Administrative Requirements From All 21 Types of Medicare Providers, Projecting 320 Million Dollars in Annual Savings

A proposed rule published today in the Federal Register would strip dozens of regulatory requirements from hospitals, nursing homes, home health agencies, and other Medicare and Medicaid providers, with CMS estimating it would return 3.26 million staff hours per year to patient care.

November 10, 2026

Policy & oversight

Federal Rural Health Program Distributes Second 10 Billion Dollar Round to All 50 States

The five-year, 50 billion dollar Rural Health Transformation Program enters year two with fresh awards for telehealth, rural hospitals, and workforce programs that many Medicare enrollees depend on.

November 9, 2026

Policy & oversight

Medicare Finalizes 2027 Home Health Rule, Covering Palliative Care and Tightening Ownership Screening

A rule published today in the Federal Register confirms that Medicare-covered skilled home health visits may now explicitly include palliative care services, and requires agencies to re-enroll with Medicare whenever the majority owner changes.

November 9, 2026

Policy & oversight

Medicare Finalizes 2027 Doctor Pay Rule, Banning Remote Monitoring Vendors and Setting a MIPS Retirement Date

A rule finalized November 4 locks in a small physician payment cut, prohibits Medicare billing for remote monitoring services handled by outside vendors, and officially schedules the end of the MIPS quality program in 2031.

November 5, 2026

Policy & oversight

Democrats Win Back Congress, Naming Medicare Oversight and Medicaid Reversal as Top Health Priorities

Democrats gained control of the House and Senate on November 3, with health care ranking among the leading voter concerns. Their declared priorities include Medicaid spending cuts enacted in 2025, Medicare Advantage insurer oversight, and drug pricing, though President Trump retains veto power.

November 5, 2026